1. Home
  2. Stock quotes
  3. Stock EyePoint Pharmaceuticals
EyePoint Pharmaceuticals logo

EyePoint Pharmaceuticals EYPT

$ 14.15 2.91%

Annual report 2025
added 03-05-2026

report update icon

Country

 usaUSA

IPO year

 -

Industry

 Biotechnology

Stock Exchange

 NASDAQ GLOBAL

Shares

 73.3 K

Market Cap[1]

 $ 1.04 M

EBITDA (LTM)

 $ -204 M

P/E (LTM)

 -4.76

P/S (LTM)

 0.02

EPS (LTM)

 -2.89

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
MorphoSys AG MorphoSys AG
MOR
 		- 2.43 % $ 254 M Nasdaq Global Select Market germanyGermany
AgeX Therapeutics AgeX Therapeutics
AGE
 		- -10.17 % $ 12.2 K NYSE American usaUSA
I-Mab I-Mab
IMAB
 		- - $ 866 M Nasdaq Global Select Market chinaChina
Midatech Pharma plc Midatech Pharma plc
MTP
 		- -18.52 % $ 27.3 M Nasdaq Global Select Market britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		- - $ 40.3 B Nasdaq Global Select Market usaUSA
Biophytis SA Biophytis SA
BPTS
 		- -13.47 % $ 169 M Nasdaq Capital Market franceFrance
Genfit SA Genfit SA
GNFT
 		- 2.54 % $ 160 B Nasdaq Global Select Market franceFrance
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		- -1.52 % $ 24.7 M Nasdaq Capital Market usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
 		$ 3.13 0.16 % $ 651 M Nasdaq Global Market,SPB usaUSA
Exelixis Exelixis
EXEL
 		$ 46.2 4.01 % $ 12.5 B Nasdaq Global Select Market,SPB usaUSA
Athira Pharma Athira Pharma
ATHA
 		- - $ 269 M Nasdaq Global Select Market usaUSA
Fortress Biotech Fortress Biotech
FBIO
 		$ 2.49 1.22 % $ 69.5 M Nasdaq Capital Market usaUSA
Fennec Pharmaceuticals Fennec Pharmaceuticals
FENC
 		$ 6.85 1.93 % $ 196 M Nasdaq Capital Market usaUSA
Galectin Therapeutics Galectin Therapeutics
GALT
 		$ 2.28 2.24 % $ 146 M Nasdaq Global Select Market usaUSA
Galapagos NV Galapagos NV
GLPG
 		$ 28.82 1.51 % $ 2.69 B Nasdaq Global Select Market belgiumBelgium
Grifols, S.A. Grifols, S.A.
GRFS
 		$ 8.4 1.51 % $ 6.83 B Nasdaq Global Select Market spainSpain
Genprex Genprex
GNPX
 		$ 0.89 0.28 % $ 830 K Nasdaq Capital Market usaUSA
BioNTech SE BioNTech SE
BNTX
 		$ 94.21 -1.35 % $ 27.2 B Nasdaq Global Select Market germanyGermany
InflaRx N.V. InflaRx N.V.
IFRX
 		$ 2.37 20.05 % $ 152 M Nasdaq Global Select Market germanyGermany
Immuron Limited Immuron Limited
IMRN
 		$ 0.82 3.97 % $ 6.82 M Nasdaq Global Select Market australiaAustralia
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
 		- - - MOEX russiaRussia
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
 		- - $ 231 M Nasdaq Global Market usaUSA
Ionis Pharmaceuticals Ionis Pharmaceuticals
IONS
 		$ 76.34 1.45 % $ 12.2 B Nasdaq Global Select Market,SPB usaUSA
Innate Pharma S.A. Innate Pharma S.A.
IPHA
 		$ 1.49 3.83 % $ 235 M Nasdaq Global Select Market franceFrance
INmune Bio INmune Bio
INMB
 		$ 1.51 -1.95 % $ 37.4 M Nasdaq Capital Market usaUSA
Kamada Ltd. Kamada Ltd.
KMDA
 		$ 8.31 1.22 % $ 260 M Nasdaq Global Select Market israelIsrael
Kymera Therapeutics Kymera Therapeutics
KYMR
 		$ 85.92 3.88 % $ 7.26 B Nasdaq Global Market usaUSA
Kazia Therapeutics Limited Kazia Therapeutics Limited
KZIA
 		$ 12.98 -3.53 % $ 1.72 B Nasdaq Global Select Market australiaAustralia
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
 		$ 23.02 2.98 % $ 3.81 B Nasdaq Global Select Market,SPB usaUSA
Liquidia Corporation Liquidia Corporation
LQDA
 		$ 41.73 3.97 % $ 3.59 B Nasdaq Capital Market usaUSA
Advaxis Advaxis
ADXS
 		- -9.65 % $ 45.9 M Nasdaq Capital Market usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
 		$ 3.56 1.71 % $ 5.86 M NYSE American israelIsrael
Aeterna Zentaris Aeterna Zentaris
AEZS
 		- 5.93 % $ 314 M Nasdaq Capital Market canadaCanada
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
 		- - $ 1.01 B Nasdaq Global Market usaUSA
Mirum Pharmaceuticals Mirum Pharmaceuticals
MIRM
 		$ 106.77 0.9 % $ 5.36 B Nasdaq Global Select Market usaUSA
CureVac N.V. CureVac N.V.
CVAC
 		- - $ 867 M Nasdaq Global Market germanyGermany
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		- - $ 26.5 M Nasdaq Global Select Market usaUSA
MannKind Corporation MannKind Corporation
MNKD
 		$ 3.88 35.49 % $ 1.19 B Nasdaq Global Market usaUSA
AIkido Pharma AIkido Pharma
AIKI
 		- 1.93 % $ 17.4 M Nasdaq Capital Market usaUSA
Mereo BioPharma Group plc Mereo BioPharma Group plc
MREO
 		$ 0.27 -3.84 % $ 660 M Nasdaq Global Select Market britainBritain
Akero Therapeutics Akero Therapeutics
AKRO
 		- - $ 3.67 B Nasdaq Global Select Market,SPB usaUSA
Aptose Biosciences Aptose Biosciences
APTO
 		- -45.71 % $ 1.2 M Nasdaq Capital Market canadaCanada
Aptinyx Aptinyx
APTX
 		- -39.0 % $ 4.57 M Nasdaq Global Select Market usaUSA
Akouos Akouos
AKUS
 		- 0.23 % $ 488 M Nasdaq Global Select Market usaUSA
Albireo Pharma Albireo Pharma
ALBO
 		- -0.23 % $ 916 M Nasdaq Capital Market usaUSA
Allakos Allakos
ALLK
 		- - $ 28.6 M Nasdaq Global Select Market,SPB usaUSA
AlloVir AlloVir
ALVR
 		- 4.14 % $ 49.1 M Nasdaq Global Select Market usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
 		$ 23.63 0.9 % $ 3.01 B Nasdaq Global Select Market,SPB usaUSA
Nanobiotix S.A. Nanobiotix S.A.
NBTX
 		$ 39.36 13.2 % $ 286 B Nasdaq Global Select Market franceFrance
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
 		- 3.16 % $ 1.9 M Nasdaq Global Select Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.